Home › Funds › BlackRock Inc › CMPX
BlackRock Inc position in CMPX
COMPASS THERAPEUTICS INC · Health Care
Latest position (Q2 2026)11.28M sh
Reported value held$24.71M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 6.82M | $12.55M | New |
| Q4 2024 | 6.89M | $9.99M | Add |
| Q1 2025 | 7.11M | $13.51M | Add |
| Q2 2025 | 6.41M | $16.67M | Reduce |
| Q3 2025 | 7.37M | $25.80M | Add |
| Q4 2025 | 9.39M | $50.42M | Add |
| Q1 2026 | 9.51M | $50.29M | Add |
| Q2 2026 | 11.28M | $24.71M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CMPX
- Vanguard Group 8.05M sh · $43.22M · Q4 2025
- Millennium Management 4.71M sh · $10.32M · Q2 2026
- Geode Capital Management 3.82M sh · $8.36M · Q2 2026
- Citadel Advisors 3.71M sh · $8.12M · Q2 2026
- Goldman Sachs Group 3.53M sh · $7.73M · Q2 2026
- AQR Capital Management 3.51M sh · $7.69M · Q2 2026
- Royce & Associates 1.34M sh · $2.93M · Q2 2026
- Fidelity Management & Research (FMR) 1.21M sh · $2.65M · Q2 2026
- Northern Trust Corp 1.14M sh · $2.50M · Q2 2026
- JPMorgan Chase & Co 789.40K sh · $1.71M · Q2 2026
- Morgan Stanley 735.19K sh · $1.61M · Q2 2026